Implant to Better Track Brain Chemical Gone Rogue After Neurotrauma
March 28, 2019 | Purdue UniversityEstimated reading time: 3 minutes

Your chances of getting a nasty migraine increase following a spinal cord injury, thanks to a chemical messenger in the brain that spikes to toxic levels, past studies have suggested.
Image Caption: An implantable sensor has the speed and precision for tracking a brain chemical known to be elevated in certain brain diseases and after a spinal cord injury. (Purdue University image/Tran Nguyen)
For treatment to get any better, researchers need to catch that split-second spike in action and closely follow its path of destruction.
Purdue University engineers have built a tiny, flexible sensor that is faster and more precise than past attempts at tracking this chemical, called glutamate. The sensor, an implantable device on the spinal cord, is primarily a research tool for testing in animal models, but could find future clinical use as a way to monitor whether a drug for neurotrauma or brain disease is working.
The group's work appears in a forthcoming issue of Biosensors and Bioelectronics.
"When you feel like you're running a fever, it doesn't matter when you check your temperature—it will probably be the same for several hours. But a glutamate spike is so fast that if you don't capture it at that moment, you miss the whole opportunity to get data," said Riyi Shi, a professor of neuroscience and biomedical engineering in Purdue's Department of Basic Medical Sciences, College of Veterinary Medicine and Weldon School of Biomedical Engineering.
Impact, such as from a car accident or tackle in football, can injure the spinal cord—also injuring the nerve structures that transport glutamate, which sends signals to excite nerve tissue for performing functions such as learning and memorizing.
Damaged nerve structures means that loads of glutamate leak out into spaces outside of cells, over-exciting and damaging them. Brain diseases, including Alzheimer's and Parkinson's, also show elevated levels of glutamate.
Devices so far either haven't been sensitive enough to detect glutamate, fast enough to capture its spike or affordable enough for long-term research projects.
Purdue researchers are addressing these issues through implantable sensors that they have 3D printed and laser-micromachined—processes that are already used regularly in the lab and industry. A YouTube video is available at https://youtu.be/hyn9SM1wdz0.
Image Caption: New sensor technology implanted in animal models can help researchers understand the role that the brain chemical glutamate plays in neurotrauma, advising more specialized treatment. (Purdue University image/Tran Nguyen)
"We wanted to create a low-cost and very fast way to build these sensors so that we can easily provide researchers with a means to measure glutamate levels in vivo," said Hugh Lee, a Purdue assistant professor of biomedical engineering, who focuses on implantable microtechnologies.
The technique allows researchers to rapidly change the size, shape and orientation of the sensors and then test in animal models without having to go through the more expensive process of microfabrication.
Measuring levels in vivo would help researchers to study how spinal cord injuries happen, as well as how brain diseases develop.
"How big of a problem is a migraine? Is too much glutamate really behind the pain, or is it that the system that cleans up glutamate is down?" Shi said.
The researchers implanted the device into the spinal cord of an animal model and then injured the cord to observe a spike. The device captured the spike immediately, whereas for current devices, researchers have had to wait 30 minutes to get data after damaging the spinal cord.
In the future, the researchers plan to create a way for the biosensors to self-clear of inflammatory cells that the body recruits to protect itself. These cells typically form a fibrous capsule around the biosensor, which blocks its sensitivity.
The technology could also allow for implanting more sensors along the spinal cord, which would help researchers to know how far glutamate spreads and how quickly.
Suggested Items
Saab Receives Order from Sweden on Giraffe 4A Radar Systems
06/20/2025 | SaabSaab has received an order from the Swedish Defence Materiel Administration (FMV) of Giraffe 4A radar systems with associated services to the Swedish Armed Forces. The order value is approximately SEK 1.4 billion with deliveries 2026-2027.
Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study
06/11/2025 | PRNewswireMicrotech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical implantations were performed on Friday, May 16, 2025, at New York-Presbyterian/Columbia University Irving Medical Center by Dr. Koji Takeda, Surgical Director for Adult Heart Transplant at New York-Presbyterian/Columbia.
Self-Healing Materials Could Unlock the Potential of Tomorrow’s Technology, Reports IDTechEx
05/22/2025 | IDTechExA sci-fi movie trope is the virtually indestructible robot, capable of operating without rest due to extended battery life, able to interact with its surroundings like a human thanks to advanced soft robotic components, and fully autonomous due to an extensive suite of sensors.
Interlink Electronics Reports Q1 2025 Result
05/15/2025 | BUSINESS WIREInterlink Electronics, Inc., a global leader in sensor technology and printed electronic solutions, reported results for the first quarter ended March 31, 2025.
Kitron Signs €7 Million Annual Manufacturing Agreement for Advanced Sensor Technology
05/09/2025 | KitronKitron has entered into a multi-year agreement with a U.S.-based customer to manufacture advanced sensor-based products intended for the European market.